Neurozym has established a scientific and business network, and we are currently looking for new business arrangements with foreign companies in order to market and sell the new probiotic product Probiozym in several EU-countries. We have had an important cooperation with Dr. Karl L. Reichelt at the Institute of Pediatric Research, University of Oslo, who has been the number one researcher in the field of food peptides and autism/ADHD.